These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35797024)

  • 1. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
    Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
    Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial.
    Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction.
    Lee JJ; Peterson AM; Kallogjeri D; Jiramongkolchai P; Kukuljan S; Schneider JS; Klatt-Cromwell CN; Drescher AJ; Brunworth JD; Piccirillo JF
    Am J Otolaryngol; 2022; 43(2):103299. PubMed ID: 34894449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Budesonide Added to Large-Volume, Low-pressure Saline Sinus Irrigation for Chronic Rhinosinusitis: A Randomized Clinical Trial.
    Tait S; Kallogjeri D; Suko J; Kukuljan S; Schneider J; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Jul; 144(7):605-612. PubMed ID: 29879268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Novel At-home Smell Assessment.
    Gupta S; Kallogjeri D; Farrell NF; Lee JJ; Smith HJ; Khan AM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):252-258. PubMed ID: 35024772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
    Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective early strategy to prevent olfactory and gustatory dysfunction in COVID-19: a randomized controlled trial.
    Jing Q; Song J; An G; Zhu E; Ai Z; Xiong L; Li C
    QJM; 2024 Jun; 117(5):348-352. PubMed ID: 37988146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
    Lerner D; Garvey K; Arrighi-Allisan A; Filimonov A; Filip P; Liu K; Ninan S; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM
    Trials; 2020 Nov; 21(1):942. PubMed ID: 33225989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
    Bachert C; Mannent L; Naclerio RM; Mullol J; Ferguson BJ; Gevaert P; Hellings P; Jiao L; Wang L; Evans RR; Pirozzi G; Graham NM; Swanson B; Hamilton JD; Radin A; Gandhi NA; Stahl N; Yancopoulos GD; Sutherland ER
    JAMA; 2016 Feb; 315(5):469-79. PubMed ID: 26836729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial.
    Tragoonrungsea J; Tangbumrungtham N; Nitivanichsakul T; Roongpuvapaht B; Tanjararak K
    Clin Otolaryngol; 2023 Mar; 48(2):182-190. PubMed ID: 36336851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
    Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
    Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.
    Hasan MJ; Rumi SKNF; Banu SS; Uddin AKMN; Islam MS; Arefin MK
    Trials; 2021 Jan; 22(1):2. PubMed ID: 33397432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal saline irrigation has no effect on normal olfaction: a prospective randomized trial.
    Liu JJ; Chan GC; Hecht AS; Storm DR; Davis GE
    Int Forum Allergy Rhinol; 2014 Jan; 4(1):39-42. PubMed ID: 24574085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer.
    Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory dysfunction and training in children with COVID-19 infection: A prospective study Post-COVID pediatric olfactory training.
    Chan KH; Thomas BJ; Gilbert DD; Tong S; Teynor NJ; Friedman NR; Herrmann BW; Gitomer SA
    Int J Pediatr Otorhinolaryngol; 2024 Jan; 176():111799. PubMed ID: 38081110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.